Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For three decades, the dietary advice was consistent and confident: choose low-fat or fat-free dairy. Avoid full-fat milk. Skip the butter. Choose reduced-fat cheese. The saturated fat in full-fat dairy, the guidelines insisted, raised LDL cholesterol […]
Breaking health research, new drug approvals, landmark clinical trials, and emerging science — summarised clearly for informed readers. Updated as major findings are published.
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy If you have ever experienced a migraine that begins with visual disturbances – zig-zag lines, blind spots, flashing lights, or a shimmering arc of light that moves across your field of vision – you have experienced […]
A major British Journal of Sports Medicine study suggests the standard 150-minute exercise guideline undershoots real heart protection by nearly 4x. Here is what the research actually found — and what it means for your routine.
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy If you’ve been diagnosed with polycystic ovary syndrome, the condition has genuinely just been renamed. On May 12, 2026, The Lancet published the result of a decade-long global consensus process — more than 50 patient and […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy When tirzepatide (Mounjaro/Zepbound) was approved, it was described as a dual GLP-1/GIP receptor agonist. Most of the attention went to GLP-1 – the hormone semaglutide (Ozempic) also targets, and the one that has dominated obesity medicine […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy In August 2023, the New England Journal of Medicine published results that changed cardiovascular medicine. The SELECT trial — the largest randomised trial of a GLP-1 drug in cardiovascular patients, 17,604 people followed for over 3 […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs are doing far […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy A landmark scientific discovery is reshaping how researchers think about human aging. For the first time, scientists have successfully transferred a longevity gene from one species to another – and the results have exceeded all expectations. […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Update, July 2026: the World Health Organization officially declared this outbreak over on 2 July 2026, after the last close contact completed quarantine with no further cases. The account below reflects the final, confirmed picture of […]
🦺Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Most people have heard that omega-3 fatty acids are good for you. Far fewer realise just how profoundly their absence damages the brain and heart — or how widespread deficiency has become, particularly […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an oral version […]
